Association of common genetic variations and idiopathic venous thromboembolism: Results from EDITh, a hospital-based case-control study

Thrombosis and Haemostasis

Volumn 103, Issue 6, 2010, Pages 1161-1169

  Delluc, Aurélien ^a,b   Gourhant, Lénaïck ^c   Lacut, Karine ^c   Mercier, Bernard ^c   Audrezet, Marie Pierre ^c   Nowak, Emmanuel ^c   Oger, Emmanuel ^a,b   Leroyer, Christophe ^a,b   Mottier, Dominique ^a,b   Gal, Grégoire Le ^a,b   Couturaud, Francis ^a,b  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

Author keywords

Factor XI; Gene mutations; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; ADRENERGIC RECEPTOR; BLOOD CLOTTING FACTOR 5;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IDIOPATHIC DISEASE; INHERITANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VENOUS THROMBOEMBOLISM; CASE CONTROL STUDY; GENETICS; HOSPITAL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; THROMBOCYTE AGGREGATION;

AGED; BLOOD COAGULATION; CASE-CONTROL STUDIES; FACTOR V; FACTOR XI; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HOSPITALS; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; PLATELET AGGREGATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTHROMBIN; RECEPTORS, ADRENERGIC; RENIN-ANGIOTENSIN SYSTEM; VENOUS THROMBOEMBOLISM;

EID: 77953169549     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-07-0430     Document Type: Article

References (21)

1. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-463.
2. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107: I22-30.
3. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
4. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
5. Hirschhorn JN. Genomewide Association Studies -- Illuminating Biologic Pathways. N Engl J Med 2009; 360: 1699-1701.
6. Bezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong C, Rowland CM, et al. Gene variants associated with deep vein thrombosis. J Am Med Assoc 2008; 299: 1306-1314.
7. Lacut K, van der Maaten J, Le Gal G, et al. Antiplatelet drugs and risk of venous thromboembolism: results from the EDITH case-control study. Haematologica 2008; 93: 1117-1118.
8. Oger E, Lacut K, Le Gal G, et al. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: A hospital-based case-control study. Thromb Res 2007; 120: 207-214.
9. Zee RYL, Cook NR, Cheng S, et al. Polymorphism in the {beta}2-Adrenergic Receptor and Lipoprotein Lipase Genes as Risk Determinants for Idiopathic Venous Thromboembolism: A Multilocus, Population-Based, Prospective Genetic Analysis. Circulation 2006; 113: 2193-2200.
10. Smith NL, Hindorff LA, Heckbert SR, et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. J Am Med Assoc 2007; 297: 489-498.
11. Hoppe B, Tolou F, Dorner T, et al. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population. Thromb Haemost 2006; 96: 465-470.
12. Tobler AR, Short S, Andersen MR, et al. The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping. J Biomol Tech 2005; 16: 398-406.
13. De la Vega FM, Lazaruk KD, Rhodes MD, et al. Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP Genotyping Assays and the SNPlex Genotyping System. Mutat Res 2005; 573: 111-135.
14. Emigh T. Comparison of tests for Hardy-Weinberg equilibrium. Biometrics 1980; 36: 627-642.
15. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
16. Meijers JCM, Tekelenburg WLH, Bouma BN, et al. High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis. N Engl J Med 2000; 342: 696-701.
17. Souto JC, Almasy L, Borrell M, et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet 2000; 67: 1452-1459.
18. Gerdes VEA, Kraaijenhagen RA, Vogels EWM, et al. Factor XI gene analysis in thrombophilia and factor XI deficiency. J Thromb Haemost 2004; 2: 1015-1017.
19. Seligsohn U. Factor XI in haemostasis and thrombosis: past, present and future. Thromb Haemost 2007; 98: 84-89.
20. Lacut K, Oger E, Le Gal G, et al. Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study. Fundam Clin Pharmacol 2004; 18: 477-482.
21. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-907. (Pubitemid 29141050)